Search - tctmd.com

Displaying 421 - 440 of 1480

Sort: Relevancy | Date

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Daily News

A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November

Yael L. Maxwell

August 14, 2019

News Daily News

High-Sensitivity Troponin Performs Well Against Traditional Tools for 30-Day MACE Prediction

Marcus A. Banks

August 13, 2019

Podcast TCTMD Talking Points

CorMicA: A Randomized Trial of Invasive Coronary Function Testing in Patients With Angina and Nonobstructive Coronary Artery Disease

August 07, 2019

News Daily News

Stroke After PCI: Rare but Rising as Patient Complexity Climbs

Todd Neale

August 05, 2019

News Daily News

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Shelley Wood

August 05, 2019

News Opinion Conversations in Cardiology

Conversations in Cardiology: The Push for High-Sensitivity Troponin

August 02, 2019

Presentation CHIP Seattle 2019

Coronary Trash (Microcatheter tips and balloon bits, etc.)

Presenter: Kate Kearney

August 02, 2019

News Daily News

Acupuncture for Angina? Chinese Study Backs Targeted Approach

Caitlin E. Cox

July 31, 2019

News Daily News

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Shelley Wood

July 23, 2019

News Conference News SCCT 2019

Chest Pain Rule-Out? For Two ED Scores, It’s a Draw

Yael L. Maxwell

July 19, 2019

News Daily News

Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients

Michael O'Riordan

July 19, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Conference News SCCT 2019

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

Yael L. Maxwell

July 16, 2019

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Daily News

Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm

Caitlin E. Cox

July 15, 2019

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

July 15, 2019

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

News Conference News EAS 2019

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Michael O'Riordan

June 05, 2019

Advertisement

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November

High-Sensitivity Troponin Performs Well Against Traditional Tools for 30-Day MACE Prediction

CorMicA: A Randomized Trial of Invasive Coronary Function Testing in Patients With Angina and Nonobstructive Coronary Artery Disease

Stroke After PCI: Rare but Rising as Patient Complexity Climbs

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Conversations in Cardiology: The Push for High-Sensitivity Troponin

Coronary Trash (Microcatheter tips and balloon bits, etc.)

Acupuncture for Angina? Chinese Study Backs Targeted Approach

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Chest Pain Rule-Out? For Two ED Scores, It’s a Draw

Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content